Drug Information

General Information
Drug ID
DR00068
Drug Name
Zinc salts
Drug Type
Small molecular drug
Indication Arthritis [ICD11: FA5Z] Preclinical [1]
TTD Drug ID
D0K8AA
DT(s) Transporting This Drug IREG1 Transporter Info Iron-regulated transporter 1 Substrate [2]
ZIP1 Transporter Info Zrt- and Irt-like protein 1 Substrate [3]
ZIP10 Transporter Info Zrt- and Irt-like protein 10 Substrate [4]
ZIP11 Transporter Info Zrt- and Irt-like protein 11 Substrate [5]
ZIP12 Transporter Info Zrt- and Irt-like protein 12 Substrate [6]
ZIP13 Transporter Info Zrt- and Irt-like protein 13 Substrate [7]
ZIP14 Transporter Info Zrt- and Irt-like protein 14 Substrate [8]
ZIP2 Transporter Info Zrt- and Irt-like protein 2 Substrate [9]
ZIP3 Transporter Info Zrt- and Irt-like protein 3 Substrate [10]
ZIP4 Transporter Info Zrt- and Irt-like protein 4 Substrate [11]
ZIP5 Transporter Info Zrt- and Irt-like protein 5 Substrate [12]
ZIP6 Transporter Info Zrt- and Irt-like protein 6 Substrate [13]
ZIP7 Transporter Info Zrt- Irt-like protein 7 Substrate [13]
ZIP8 Transporter Info Zrt- and Irt-like protein 8 Substrate [14]
ZIP9 Transporter Info Zrt- and Irt-like protein 9 Substrate [13]
ZNT1 Transporter Info Zinc transporter 1 Substrate [14]
ZNT10 Transporter Info Zinc transporter 10 Substrate [15]
ZNT2 Transporter Info Zinc transporter 2 Substrate [16]
ZNT3 Transporter Info Zinc transporter 3 Substrate [17]
ZNT4 Transporter Info Zinc transporter 4 Substrate [18]
ZNT5 Transporter Info Zinc transporter 5 Substrate [19]
ZNT6 Transporter Info Zinc transporter 6 Substrate [19]
ZNT7 Transporter Info Zinc transporter 7 Substrate [20]
ZNT8 Transporter Info Zinc transporter 8 Substrate [21]
ZNT9 Transporter Info Zinc transporter 9 Substrate [22]
Drug-Transporter Activity Data
Drug-Transporter Activity Data ZIP2 Transporter Info Km = 3 microM Human embryonic kidney cells (HEK293)-ZIP2 [9]
ZIP5 Transporter Info Km = 2.1 microM Human embryonic kidney cells (HEK293)-ZIP5 [12]
References
1 Zinc monoglycerolate: a slow-release source of zinc with anti-arthritic activity in rats. Agents Actions. 1990 Aug;31(1-2):47-58.
2 Ferroportin-mediated iron transport: expression and regulation. Biochim Biophys Acta. 2012 Sep;1823(9):1426-33.
3 SLC transporters as a novel class of tumour suppressors: identity, function and molecular mechanisms. Biochem J. 2016 May 1;473(9):1113-24.
4 Zinc transporter SLC39A10/ZIP10 facilitates antiapoptotic signaling during early B-cell development. Proc Natl Acad Sci U S A. 2014 Aug 12;111(32):11780-5.
5 Gastric and colonic zinc transporter ZIP11 (Slc39a11) in mice responds to dietary zinc and exhibits nuclear localization. J Nutr. 2013 Dec;143(12):1882-8.
6 The zinc transporter ZIP12 regulates the pulmonary vascular response to chronic hypoxia. Nature. 2015 Aug 20;524(7565):356-60.
7 Promotion of vesicular zinc efflux by ZIP13 and its implications for spondylocheiro dysplastic Ehlers-Danlos syndrome. Proc Natl Acad Sci U S A. 2012 Dec 18;109(51):E3530-8.
8 SLC39A14 deficiency alters manganese homeostasis and excretion resulting in brain manganese accumulation and motor deficits in mice. Proc Natl Acad Sci U S A. 2018 Feb 20;115(8):E1769-E1778.
9 Reassessment of the Transport Mechanism of the Human Zinc Transporter SLC39A2. Biochemistry. 2018 Jul 3;57(26):3976-3986.
10 The SLC39 family of zinc transporters. Mol Aspects Med. 2013 Apr-Jun;34(2-3):612-9.
11 Extreme population differences in the human zinc transporter ZIP4 (SLC39A4) are explained by positive selection in Sub-Saharan Africa. PLoS Genet. 2014 Feb 20;10(2):e1004128.
12 The mammalian Zip5 protein is a zinc transporter that localizes to the basolateral surface of polarized cells. J Biol Chem. 2004 Dec 3;279(49):51433-41.
13 A ZIP6-ZIP10 heteromer controls NCAM1 phosphorylation and integration into focal adhesion complexes during epithelial-to-mesenchymal transition. Sci Rep. 2017 Jan 18;7:40313.
14 Zinc transporters ZnT1 (Slc30a1), Zip8 (Slc39a8), and Zip10 (Slc39a10) in mouse red blood cells are differentially regulated during erythroid development and by dietary zinc deficiency. J Nutr. 2008 Nov;138(11):2076-83.
15 Mutations in SLC30A10 cause parkinsonism and dystonia with hypermanganesemia, polycythemia, and chronic liver disease. Am J Hum Genet. 2012 Mar 9;90(3):467-77.
16 Compound heterozygous mutations in SLC30A2/ZnT2 results in low milk zinc concentrations: a novel mechanism for zinc deficiency in a breast-fed infant. PLoS One. 2013 May 31;8(5):e64045.
17 Loss of synaptic Zn2+ transporter function increases risk of febrile seizures. Sci Rep. 2015 Dec 9;5:17816.
18 Mutation analysis of the zinc transporter gene SLC30A4 reveals no association with periodic catatonia on chromosome 15q15. J Neural Transm (Vienna). 2003 Nov;110(11):1329-32.
19 Altered expression of two zinc transporters, SLC30A5 and SLC30A6, underlies a mammary gland disorder of reduced zinc secretion into milk. Genes Nutr. 2015 Sep;10(5):487.
20 Znt7 (Slc30a7)-deficient mice display reduced body zinc status and body fat accumulation. J Biol Chem. 2007 Dec 21;282(51):37053-63.
21 Zinc transporter 8 (ZnT8) and cell function. Trends Endocrinol Metab. 2014 Aug;25(8):415-24.
22 SLC30A9 mutation affecting intracellular zinc homeostasis causes a novel cerebro-renal syndrome. Brain. 2017 Apr 1;140(4):928-939.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.